Skip to main content
. 2016 Mar 25;11(3):e0150785. doi: 10.1371/journal.pone.0150785

Fig 1. Study subjects classified according to status as carriers of c.−3383C>G PCSK9 and c.*52G>A LDLR variants and response of LDL cholesterol levels to Armolipid Plus.

Fig 1